Synthesis and antiviral evaluation of some novel tricyclic pyrazolo[3,4-b]indole nucleosides

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 5, 2004, Pages 805-812

  Williams, John D ^a   Drach, John C ^a   Townsend, Leroy B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antiviral; Nucleoside analogs; Pyrazolo 3,4 b indole

Indexed keywords

3 CYANO 2 CHLOROINDOLE; 3 FORMYL 2 CHLOROINDOLE; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; HYDRAZINE; INDOLE DERIVATIVE; NUCLEOSIDE DERIVATIVE; PYRAZOLO[3,4 B]INDOLE NUCLEOSIDE DERIVATIVE; TRICYCLIC AROMATIC COMPOUND; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; IC 50; NONHUMAN; PUBLICATION; SEPARATION TECHNIQUE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; HERPESVIRUS 1, HUMAN; HUMANS; INDOLES; INHIBITORY CONCENTRATION 50; NUCLEOSIDES; PYRAZOLES;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 3142660212     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120039253     Document Type: Article

References (19)

1. Alford, C.A.; Britt, W.J. Cytomegalovirus. In The Human Herpesviruses; Raven Press: New York, 1993; 227-256.
2. Ho, M. Cytomegalovirus: Biology and Infection; Plenum Medical Book Company: New York, 1982; 309 pp.
3. Faulds, D.; Heel, R.C. Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990, 39, 597-638.
4. Curran, M.; Noble, S. Valganciclovir. Drugs 2001, 61, 1145-1150.
5. Hitchcock, M.J.M.; Jaffe, H.S.; Martin, J.C.; Stagg, R.J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antivir. Chem. Chemother. 1996, 7, 115-127.
6. Wagstaff, A.J.; Bryson, H.M. Foscarnet: a reappraisal of its antiviral activity, pharmacokinetic properties, and therapeutic use in immunocompromised patients with viral infections. Drugs 1994, 48, 199-226.
7. Perry, C.M.; Barman-Balfour, J.A. Fomivirsen. Drugs 1999, 57, 375-380.
8. Townsend, L.B.; Devivar, R.V.; Turk, S.R.; Nassiri, M.R.; Drach, J.C. Design, synthesis, and antiviral activity of certain 2,5,6-Trihalo-1-(β-D- ribofuranosyl)benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
9. Good, S.S.; Owens, B.S.; Townsend, L.B.; Drach, J.C. The disposition in rats and monkeys of 2-Bromo-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (BDCRB) and its 2,5,6-Trichloro Congener. Antivir. Res. 1994, 23(S), 103.
10. Chen, J.J.; Wei, Y.; Drach, J.C.; Townsend, L.B. Synthesis and antiviral evaluation of trisubstituted indole N-nucleosides as analogues of 2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole (TCRB). J. Med. Chem. 2000, 43, 2449-2456.
11. Williams, J.D.; Chen, J.J.; Drach, J.C.; Townsend, L.B. Synthesis and antiviral activity of 3-formyl-and 3-cyano-2,5,6-Trichloroindole nucleoside analogs. J. Med. Chem. Submitted.
12. Monge, A.; Palop, J.; Ramirez, C.; Font, M.; Femandez-Alvarez, E. New 5H-1,2,4-Triazino[5,6-b]indole and aminoindole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation, anti-hypertensive agents and thromboxane synthetase inhibitors. Eur. J. Med. Chem. Chim. Ther. 1991, 26, 179-188.
13. Ruccia, M.; Vivona, N.; Cusmano, G.; Marino, M.L.; Piozzi, F. Addition reactions of heterocycles IV: indoles and nitrilimines. Tetrahedron 1973, 29, 3159-3164.
14. Laude, B.; Soufiaoui, M.; Arriau, J. Cycloadditions dipolaires-1,3 II. Addition des Diarylnitrilimines au N-méthyl-indole. Etude expérimentale et essai d'interprétation. J. Heterocycl. Chem. 1977, 14, 1183-1189.
15. Shipman, C., Jr.; Smith, S.H.; Carlson, R.H.; Drach, J.C. Antiviral activity of arabinofuranosyladenosine and arabinofuranosylhypoxanthine in herpes simplex virus-infected KB cells. Antimicrob. Agents Chemother. 1976, 9, 120-127.
16. Turk, S.R.; Shipman, C., Jr.; Nassiri, M.R.; Genzlinger, G.; Krawczyk, S.H.; Townsend, L.B.; Drach, J.C. Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus. Antimicrob. Agents Chemother. 1987, 31, 544-550.
17. Prichard, M.N.; Turk, S.R.; Coleman, L.A.; Engelhardt, S.L.; Shipman, C., Jr.; Drach, J.C. A microtiter virus yield reduction assay for the evaluation of antiviral compounds. J. Virol. Methods 1990, 28, 101-106.
18. Prichard, M.N.; Shipman, C., Jr. A three dimensional model to analyze drug-drug interactions. Antivir. Res. 1990, 14, 181-206.
19. Prichard, M.N.; Prichard, L.E.; Baguley, W.A.; Nassiri, M.R.; Shipman, C., Jr. Three-dimensional analysis of synergistic cytotoxicity of ganciclovir and zidovudine. Antivir. Res. 1991, 35, 1060-1065.